| 000 | 01309 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514042837.0 | ||
| 264 | 0 | _c20021122 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0007-0963 | ||
| 024 | 7 |
_a10.1046/j.1365-2133.2002.04864.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Doorn, R | |
| 245 | 0 | 0 |
_aFollicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cSep 2002 |
||
| 300 |
_a598-601 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcneiform Eruptions _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aQuinazolines _xadverse effects |
| 700 | 1 | _aKirtschig, G | |
| 700 | 1 | _aScheffer, E | |
| 700 | 1 | _aStoof, T J | |
| 700 | 1 | _aGiaccone, G | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 147 _gno. 3 _gp. 598-601 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2133.2002.04864.x _zAvailable from publisher's website |
| 999 |
_c12088582 _d12088582 |
||